NEW YORK--(BUSINESS WIRE)--IRX Therapeutics, a privately-held company dedicated to the development and commercialization of novel drugs for the treatment of cancer and viral diseases, today announced that Carol R. Epstein, M.D. has joined the Company as Chief Medical Officer. She is responsible for all activities related to clinical development and medical affairs.
